No photo of Jeffrey A Allen
Contact Expert

View Scopus Profile

Jeffrey A Allen

20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10%(Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion(Human), 10% (GAMMAGARD LIQUID/KIOVIG)

Allen, J. A.

Baxalta US Inc.

11/14/19 → 5/31/22

Project: Research project

    • A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects with Guillain-Barre Syndrome

    Allen, J. A.

    ANNEXON, INC

    10/1/19 → 9/30/22

    Project: Research project

    • A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-2401 in MyastheniaGravis Patients

    Allen, J. A.

    IMMUNOVANT, INC.

    1/1/19 → 12/31/21

    Project: Research project

    • Intravenous Immunoglobulin (IVIg) Treatment-Related

    Allen, J. A.

    CSL BEHRING GMBH

    6/1/14 → 12/31/20

    Project: Research project

    • A Phase III, Double-Blind, Randomized, Placebo-Controlle

    Allen, J. A.

    ViroMed Co., Ltd.

    3/1/16 → 12/31/19

    Project: Research project

    • Research Output

    Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?

    Allen, J. A., Gelinas, D. F., Freimer, M., Runken, M. C. & Wolfe, G. I., Jan 15 2020, In : Journal of the Neurological Sciences. 408, 116497.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy during Routine Care: A Review of Clinical and Laboratory Assessment Measures

    Allen, J. A., Merkies, I. S. J. & Lewis, R. A., Jan 1 2020, (Accepted/In press) In : JAMA Neurology.

    Research output: Contribution to journal › Review article

    • Rituximab in refractory chronic inflammatory demyelinating polyneuropathy

    Muley, S. A., Jacobsen, B., Parry, G., Usman, U., Ortega, E., Walk, D., Allen, J., Pasnoor, M., Varon, M. & Dimachkie, M. M., May 1 2020, In : Muscle and Nerve. 61, 5, p. 575-579 5 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    The Misdiagnosis of CIDP: A Review

    Allen, J. A., Jan 1 2020, (Accepted/In press) In : Neurology and Therapy.

    Research output: Contribution to journal › Review article

    Open Access

    • Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

    on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations